Patent ID: 6284289
Filing Date: 2001-09-04
Classification: A61K,A61P

Abstract:
A pharmaceutical composition for the treatment of herpes simplex infections, comprising a quaternary ammonium compound in a concentration effective to exhibit virucidal activity against herpes simplex virus, an antiviral agent and a pharmaceutically acceptable base, wherein the quaternary ammonium compound is present in a range from about 0.1% to about 5% and is selected from the group consisting of cetrimide and a benzalkonium compound; and the antiviral agent is present in a range from about 0.01% to about 3% and is selected from the group consisting of an acyclovir, bromylvinyldesoxuridine, 3-fluorothymidine, idoxuridine, propyl gallate, ethyl gallate, proanthocyanides and glucosamine, wherein the quaternary ammonium compound and the antiviral agent are mutually compatible.